GDF15 Antikörper (N-Term, Variant H)
Kurzübersicht für GDF15 Antikörper (N-Term, Variant H) (ABIN2273044)
Target
Alle GDF15 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- N-Term, Variant H
-
Kreuzreaktivität
- Human, Makake
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu Mc
-
Produktmerkmale
- GDF15, H Variant (Growth/Differentiation Factor 15, GDF-15, Placental Bone Morphogenetic Protein, Placental TGF-beta, Macrophage Inhibitory Cytokine 1, MIC-1, Prostate Differentiation Factor, NSAID-activated Gene 1 Protein, NAG-1, NSAID-regulated Gene 1 Protein, NRG-1, MIC1, PDF, PLAB, PTGFB)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- Synthetic peptide corresponding to human NAG-1 at N-terminal.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in 0.02M potassium phosphate, 0.15M sodium chloride, pH 7.2, 0.01 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- GDF15 (Growth Differentiation Factor 15 (GDF15))
-
Andere Bezeichnung
- GDF15
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-